CHD Chemicals Ltd FY26 Results Marred by Adverse Auditor Opinion

Net Loss Widens to ₹31.38 Crore; Revenue Declines to ₹525.32 Crore.

Reader Takeaway: Severe governance concerns from adverse auditor opinion; declining revenue and widening losses.

What just happened

CHD Chemicals Ltd has announced its financial results for the year ended March 31, 2026. The company reported a net loss of ₹31.38 crore, a significant increase from the ₹19.64 crore loss in the previous fiscal year. Revenue from operations also saw a decline, dropping to ₹525.32 crore from ₹688.45 crore in the prior year.

Why this matters

The most critical aspect of this filing is the 'Adverse Opinion' issued by GAMS & Associates LLP, the company's auditor. An adverse opinion is the most severe form of audit opinion, indicating that the financial statements are materially misstated and do not conform to the applicable accounting standards or provide a true and fair view of the company's financial position.

The backstory

In the fiscal year ended March 31, 2025, CHD Chemicals Ltd had already reported a net loss of ₹19.64 crore on revenues of ₹688.45 crore. The current results show a worsening trend in both profitability and top-line performance.

What changes now

The adverse auditor's opinion fundamentally questions the reliability of CHD Chemicals Ltd's reported financial figures. Investors and stakeholders should view the disclosed financial data with extreme caution. The company will likely face scrutiny from regulators and stock exchanges regarding this severe audit qualification.

Risks to watch

The primary risk for investors is the lack of transparent and accurate financial reporting, compounded by declining operational performance. The adverse opinion suggests potential underlying issues within the company's financial management and compliance framework. Further deterioration in financial health and potential regulatory actions are significant risks.

Auditor's Adverse Opinion Details

GAMS & Associates LLP explicitly stated that the financial statements did not meet the requirements of the Companies Act, 2013, and failed to present a true and fair view in accordance with Indian Accounting Standards (Ind AS). They also noted that management did not prepare the statements in compliance with the applicable financial reporting framework.

Financial Performance Analysis

• Revenue Decline: Revenue from operations fell by ₹163.13 crore to ₹525.32 crore in FY26 from ₹688.45 crore in FY25.
• Widening Loss: The net loss expanded by ₹11.74 crore to ₹31.38 crore in FY26 compared to ₹19.64 crore in FY25.
• Earnings Per Share: Basic and diluted EPS stood at -₹0.31 for FY26.

What to track next

Investors should closely monitor any response from CHD Chemicals Ltd to the auditor's adverse opinion, including steps being taken to rectify the accounting and reporting issues. Additionally, any communication from regulatory bodies like SEBI or the stock exchanges regarding this matter will be crucial.